Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-2012 | 09-2012 | 08-2012 | 06-2012 | 05-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 4,090 | N/A | 320 | N/A |
| Other current assets | 0 | 410 | 0 | 290 | 0 |
| TOTAL | $N/A | $4,500 | $N/A | $610 | $N/A |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $4,550 | $N/A | $660 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 170 | 0 | 320 | 0 |
| Accrued Expenses | N/A | 1,310 | N/A | 1,470 | N/A |
| TOTAL | $N/A | $1,480 | $N/A | $2,690 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,480 | $N/A | $2,690 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 4 |
| Common Shares | N/A | 172,540 | N/A | 170,250 | N/A |
| Retained earnings | N/A | -193,440 | N/A | -194,640 | N/A |
| Other shareholders' equity | 0 | 3,000 | 0 | 1,150 | 0 |
| TOTAL | $N/A | $3,070 | $N/A | $-2,030 | $N/A |
| Total Liabilities And Equity | $0 | $4,550 | $0 | $660 | $0 |